Pharmacologic targeting of the P-TEFb complex as a therapeutic strategy for chronic myeloid leukemia
Yingjie Qing(China Pharmaceutical University), Hui Hui(China Pharmaceutical University)
Cited by 11
Related Papers
Natural HDAC‐1/8 inhibitor baicalein exerts therapeutic effect in CBF‐AML
|Clinical and Translational Medicine|2020|46
LW-213 induces cell apoptosis in human cutaneous T-cell lymphomas by activating PERK–eIF2α–ATF4–CHOP axis
|Acta Pharmacologica Sinica|2020|31
PLSCR1/IP3R1/Ca2+ axis contributes to differentiation of primary AML cells induced by wogonoside
|Cell Death and Disease|2017|23
Wogonin reverses the drug resistance of chronic myelogenous leukemia cells to imatinib through CXCL12-CXCR4/7 axis in bone marrow microenvironment
|Annals of Translational Medicine|2020|16